U.S. FDA approves TG Therapeutics’ multiple sclerosis drug; shares surge
By Sriparna Roy and Khushi Mandowara (Reuters) – TG Therapeutics Inc said on Wednesday that the U.S. health regulator had approved its monoclonal antibody for treating patients with relapsing forms of multiple…